• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

GM Instruments, Sensonics partner on nasal and oral measurement devices

June 2, 2021 By Sean Whooley

Sensonics GM InstrumentsGM Instruments announced today that it partnered with Sensonics to develop devices for the quantitative assessment of nasal and oral function.

The companies tout the first-of-its-kind partnership as a bringing together of sensory and engineering expertise for evaluating and treating nasal and oral diseases.

Additionally, the companies expect the partnership to establish the influences of pharmacologic interventions for the function of the nose and mouth, according to a news release. The companies will promote, co-distribute and co-develop equipment they consider critical for nasal and oral measurement.

One application pursued through the partnership will include providing accurate functional measures to assess the effects of CPAP and other treatments for obstructive sleep apnea on nasal function. The company also plans to assess the efficacy and side-effects of intranasally administered drugs.

“With this strong collaboration and the addition of Sensonics International’s smell and taste test products to our product portfolio, we have the opportunity to extend our market by creating an end-to-end solution in testing for nasal function and olfactory/gustatory dysfunction across many specialties. We are changing the standard of care to improve patient outcomes and manage their health with better testing and assessments,” GM Instruments VP of sales, North America Dr. Karen Parker Davidson said in the release.

“Also, the addition of olfactory products positions GM Instruments, Ltd. and Sensonics International as market leaders in nasal drug and vaccine clinical trials by adding the rhinometric nasal airway resistance measurements to olfactory testing requirements stated in the current guidelines of the FDA,” Davidson said. “Nasal airway resistance can have an impact on the bioavailability and delivery of nasal pharmaceuticals and vaccines.”

Filed Under: Business/Financial News, Contract Services, Drug-Device Combinations, Otolaryngology Ear, Nose & Throat, Pharmaceuticals Tagged With: GM Instruments, Sensonics

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS